NSPR
InspireMD, Inc.
Healthcare — Medical Devices
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Price History
Fundamentals
| Market Cap | $30.45M |
| P/E Ratio (TTM) | - |
| Forward P/E | -1.07 |
| EPS (TTM) | $-0.70 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 122.20% |
| ROE | -142.60% |
| Debt/Equity | 7.13 |
| Recommendation | None |
| Analyst Target | $3.67 |
| Analysts | 3 |
| Next Earnings | Aug 17, 2026 BMO |
| Indexes | - |
Technical Indicators
| RSI (14) | 11.1 |
| Beta | 0.78 |
| SMA 20 | $0.70 |
| SMA 40 | $0.72 |
| 52-Week High | $2.93 |
| 52-Week Low | $0.63 |
| 50-Day Avg | $0.77 |
| 200-Day Avg | $1.48 |
| Avg Volume | 312.5K |
| Volume | 72.5K |
Performance Analysis
BULLISHNSPR shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Aug 01, 2026 04:15 UTC
Back to Screener Export Report